Literature DB >> 26672782

Perspective: Enforce the clinical guidelines.

Monique Roobol1.   

Abstract

Mesh:

Substances:

Year:  2015        PMID: 26672782     DOI: 10.1038/528S123a

Source DB:  PubMed          Journal:  Nature        ISSN: 0028-0836            Impact factor:   49.962


× No keyword cloud information.
  5 in total

1.  Correlation between stage shift and differences in mortality in the European Randomised study of Screening for Prostate Cancer (ERSPC).

Authors:  Leonard P Bokhorst; Marco Zappa; Sigrid V Carlsson; Maciej Kwiatkowski; Louis Denis; Alvaro Paez; Jonas Hugosson; Sue Moss; Anssi Auvinen; Monique J Roobol
Journal:  BJU Int       Date:  2016-05-20       Impact factor: 5.588

2.  Targeted Contrast Agent Specific to an Oncoprotein in Tumor Microenvironment with the Potential for Detection and Risk Stratification of Prostate Cancer with MRI.

Authors:  Zheng Han; Yajuan Li; Sarah Roelle; Zhuxian Zhou; Yuchi Liu; Rob Sabatelle; Aidan DeSanto; Xin Yu; Hui Zhu; Cristina Magi-Galluzzi; Zheng-Rong Lu
Journal:  Bioconjug Chem       Date:  2017-03-09       Impact factor: 4.774

3.  Comparative Study of Blood-Based Biomarkers, α2,3-Sialic Acid PSA and PHI, for High-Risk Prostate Cancer Detection.

Authors:  Montserrat Ferrer-Batallé; Esther Llop; Manel Ramírez; Rosa Núria Aleixandre; Marc Saez; Josep Comet; Rafael de Llorens; Rosa Peracaula
Journal:  Int J Mol Sci       Date:  2017-04-17       Impact factor: 5.923

4.  Screening for prostate cancer: are organized screening programs necessary?

Authors:  Monique J Roobol
Journal:  Transl Androl Urol       Date:  2018-02

Review 5.  Personalized strategies in population screening for prostate cancer.

Authors:  Sebastiaan Remmers; Monique J Roobol
Journal:  Int J Cancer       Date:  2020-06-03       Impact factor: 7.396

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.